Brief clinical observation
Antiphospholipid antibodies and atherosclerosis

https://doi.org/10.1016/0002-9343(92)90760-9Get rights and content

References (10)

There are more references available in the full text version of this article.

Cited by (24)

  • Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease

    2000, American Journal of Medicine
    Citation Excerpt :

    We found that about 18% of the patients with peripheral arterial disease had elevated titers of anticardiolipin antibodies, a prevalence that was significantly greater than in control patients of similar age and sex. Although arterial thrombosis in the lower limbs appears to be rare in patients with the antiphospholipid syndrome (1–4), several cases or small series of patients with antiphospholipid antibodies and peripheral arterial occlusive disease have been reported (23–30). Among 234 vascular surgery patients, for example, Taylor et al (21) found 60 patients with elevated titers of antiphospholipid antibodies (anticardiolipin antibodies [IgG, IgM, or IgA] or lupus anticoagulant), including 18% with IgG or IgM anticardiolipin antibodies.

  • Renal manifestations of the antiphospholipid syndrome

    1994, Seminars in Arthritis and Rheumatism
  • Primary antiphospholipid syndrome

    1993, The American Journal of Medicine
  • What criteria to define antiphospholipid syndrome?

    1993, La Revue de medecine interne
View all citing articles on Scopus
View full text